戻る Agenda
Rare Diseases in Canada; Diagnostic Therapeutic and Regulatory Challenges
Session Chair(s)
Matthew Ryan
Senior Policy Analyst; Policy, Planning and International Affairs Directorate
Health Canada, Canada
Deirdre Cozier
Director, Global Regulatory Affairs
Pharmascience, Canada
Rare diseases have in the past few years emerged from the shadows into the Canada’s collective consciousness. The appreciation of their overall frequency, the degree to which they are undiagnosed, and even more so untreated, has identified them as one of Canada’s greatest unmet medical and societal needs. Nonetheless, the Canadian rare diseases landscape is changing in Canada with its international lead in rare disease diagnostics and recent launch of a national rare disease strategy.
The keynote presentation will review these developments and the unique therapeutic challenges facing this aggregate common problem, outlining approaches and options for moving the diagnosis and care for rare diseases forward.
Speaker(s)
Keynote Address
Alex Mackenzie, MD
Children's Hospital of Eastern Ontario (CHEO) Research Institute, Canada
Physician, Division of Endocrinolgy